Henshaw Capital’s BeOne Medicines Ltd ONC Stock Holding History

Henshaw Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$919K	Hold	3,224	–	–	0.03%	128
2026 Q1	$957K	Hold	3,224	–	–	0.04%	116
2025 Q4	$979K	Sell	3,224 -1,023	-24%	-$335K	0.04%	117
2025 Q3	$1.45M	Buy	4,247 +3,224	+315%	+$979K	0.05%	98
2025 Q2	$248K	Hold	1,023	–	–	0.01%	287
2025 Q1	$278K	Buy	+1,023	New	+$239K	0.01%	280
2024 Q4	–	Sell	-1,023	Closed	-$230K	–	308
2024 Q3	$230K	Sell	1,023 -1,750	-63%	-$315K	0.01%	297
2024 Q2	$396K	Hold	2,773	–	–	0.02%	205
2024 Q1	$434K	Buy	2,773 +1,350	+95%	+$217K	0.02%	194
2023 Q4	$257K	Hold	1,423	–	–	0.01%	258
2023 Q3	$256K	Sell	1,423 -710	-33%	-$140K	0.01%	249
2023 Q2	$380K	Hold	2,133	–	–	0.02%	152
2023 Q1	$460K	Hold	2,133	–	–	0.03%	131
2022 Q4	$469K	Hold	2,133	–	–	0.03%	125
2022 Q3	$288K	Hold	2,133	–	–	0.02%	209
2022 Q2	$345K	Hold	2,133	–	–	0.02%	194
2022 Q1	$402K	Hold	2,133	–	–	0.02%	192
2021 Q4	$578K	Hold	2,133	–	–	0.03%	154
2021 Q3	$774K	Hold	2,133	–	–	0.05%	128
2021 Q2	$732K	Hold	2,133	–	–	0.05%	133
2021 Q1	$742K	Hold	2,133	–	–	0.05%	130
2020 Q4	$551K	Buy	2,133 +382	+22%	+$105K	0.04%	150
2020 Q3	$502K	Hold	1,751	–	–	0.04%	151
2020 Q2	$330K	Buy	+1,751	New	+$285K	0.03%	196
2020 Q1	–	Sell	-1,430	Closed	-$237K	–	324
2019 Q4	$237K	Buy	+1,430	New	+$238K	0.02%	239

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Henshaw Capital's ONC Position: Q2 2026 in Review

Henshaw Capital held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 3,224 shares worth $919K. The position accounts for 0.03% of the portfolio, ranked #128.

Henshaw Capital first reported a position in ONC in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.45M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Henshaw Capital held 3,224 shares of BeOne Medicines Ltd worth $919K as of Q2 2026.
Henshaw Capital left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up 0.03% of Henshaw Capital's portfolio in Q2 2026, its #128 holding.
Henshaw Capital first reported a position in BeOne Medicines Ltd in Q4 2019 and has held it in 25 quarters since.
Henshaw Capital's BeOne Medicines Ltd position peaked at $1.45M in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Henshaw Capital's 13F filing for Q2 2026, filed 12 Aug 2026.